Related Experiment Video
Updated: Jun 22, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Evaluation of genetic association between celiac disease and type 1 diabetes
Sayyad Malekahmadi1, Nastaran Asri2, Flora Forouzesh1
1Department of Genetics, Faculty of Advanced Science and Technology, Tehran MedicalSciences, Islamic Azad University, Tehran, Iran.
Insights
This study found increased TNF-α mRNA in celiac disease (CD), type 1 diabetes (T1D), and comorbid CD/T1D patients. These immune markers may help diagnose these autoimmune conditions.
Area of Science:
- Immunology
- Genetics
- Autoimmune Disorders
Background:
- Celiac disease (CD) and type 1 diabetes (T1D) are chronic autoimmune disorders sharing common genetic factors.
- Investigating shared immune dysregulation is crucial for understanding and managing these conditions.
Purpose of the Study:
- To explore immune regulation differences in patients with CD, T1D, and both conditions.
- To identify potential immune biomarkers for distinguishing these patient groups.
Main Methods:
- Analyzed mRNA expression of TNF-α, IL-6, IL-2, and CTLA4 in peripheral blood.
- Included patients with CD, T1D, comorbid CD/T1D, and healthy controls (HCs).
Main Results:
- Significantly increased TNF-α mRNA levels were observed in CD, T1D, and CD/T1D patients compared to HCs.
- CTLA4 mRNA levels were significantly decreased, and IL-2 mRNA levels were increased in CD and CD/T1D patients versus HCs.
- No significant differences in IL-6 mRNA expression were found between groups.
Conclusions:
- TNF-α mRNA shows potential as a diagnostic biomarker for CD, T1D, and comorbid CD/T1D.
- Findings enhance understanding of shared mechanisms in CD and T1D, aiding diagnostic and therapeutic advancements.
Purpose:
Celiac disease (CD) is a chronic autoimmune disorder with a common genetic pathogenesis with type 1 diabetes (T1D). This study aimed to investigate the immune regulation in patients with both CD and T1D.
Methods:
A total of 29 CD patients, 29 T1D patients, and 16 patients with both CD and T1D, along with 30 healthy controls (HCs) were included. The mRNA expression levels of TNF-α, IL-6, IL-2, and CTLA4 were evaluated in peripheral blood samples.
Results:
The results showed that in patients with CD, T1D and CD/T1D, TNF-α mRNA levels were significantly increased (P = 0.0009, 0.0001, and 0.008, respectively), while CTLA4 mRNA levels were significantly decreased in them compared to the control group (P = 0.0009, 0.0001, and 0.004, respectively). IL-2 mRNA expression levels were also significantly higher in CD (P = 0.01) and comorbid CD/T1D (P = 0.01) patients than in the control group. There was no significant difference in terms of IL-6 expression between studied groups (P > 0.05).
Conclusions:
TNF-α mRNA exhibited potential diagnostic value for distinguishing CD, T1D, and comorbid CD/T1D patients from HCs. These findings contribute to our understanding of the shared genetic factors and potential mechanisms underlying CD and T1D, which can aid in improved diagnostic methods and treatment approaches for these conditions.
More Related Videos
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
10:27Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Psychoneuroimmunology: Diabetes and Cancer
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...